Search results

  1. P

    Pharmacokinetic Drug Interactions

    Description This is a presentation about banned drugs, concept of therapeutic window, different mechanisms and alterations in absorption. PHARMACOKINETIC DRUG INTERACTIONS DRUGS REMOVED FROM THE MARKET DURING THE 1990s DRUG Astemizole CATEGORY antihistamine REASON serious metabolic drug...
  2. P

    National Patient Safety Goals 2009

    Description The PPT explains National Patient Safety Goals, Patient Safety Goals, medical safety, Influenza & Pneumococcal Disease, Risk Assessment and management. 2009 National Patient Safety Goals ?The purpose of The Joint Commission’s National Patient Safety Goals (NPSGs) is to promote...
  3. P

    Medical Management of Glaucoma

    Description Presentation about treatment algorithm, IOP definition, Monotherapy, VASOPROTECTION/NEUROPROTECTION and GLAUCOMA MANAGEMENT. INNOVATIONS IN THE MEDICAL MANAGEMENT OF GLAUCOMA Glaucoma: Treatment Goal “The goal of glaucoma treatment is to preserve the visual field of patients and...
  4. P

    Maternal and Newborn Healthcare Management

    Description This is a presentation explains and touches topics like newborn deaths, Essential Newborn Care Interventions, protection, Monitoring, Eye care and Immunization. Maternal and Newborn Healthcare Management Newborn Deaths ? 8.1 million infant deaths (1993) 3.9 million (48%) newborn...
  5. P

    Hospitals and Community Health & Development

    Description This is a presentation about Emmanuel Hospital Association, Organizational Objectives, Health Care Financing -India, Medical expenses and impoverishment and Price variations in drugs. Hospitals and Community Health & Development Outline of the Presentation • Community health &...
  6. P

    Hospital practice access to healthcare

    Description The PPT explains on World Health Professions Alliance, factors of global healthcare, drugs, WHO and good pharmacy practice (GPP). HOSPITAL PRACTICEACCESS TO HEALTHCARE World Health Professions Alliance The WHPA: • Unique alliance of global professional health organisations •...
  7. P

    Healthcare management of elderly people

    Description The presentation highlights on management of GERIATRIC patients, processes, care models along with effectiveness and costing. HEALTH CARE NEEDS IN THE ELDERLY Background ? Population aging ? Increase of care needs ? Societal and family structure changes ? The family as the main...
  8. P

    Healthcare india

    Description Healthcare in India presentation includes NREGA, medical tourism , emerging trends and assessment on health industry. HEALTH CARE in INDIA National Rural Health Mission • Reduction in IMR and MMR • Universal access to essentials like women and child health, water, sanitation...
  9. P

    Essential Drugs India

    Description The report about National List of Essential Medicines 2003 and List of Essential Medicines. doc_516242555.pdf
  10. P

    Consumer Protection for Pharma Industry

    Description This is a documentation on consumer protection in the pharma industry by defining types of consumers, complaints, structure of consumer forum, regulation of the medicine industry. Consumer Protection Introduction The industrial revolution and the development in the international...
  11. P

    Pharma Prostavital

    Description The doc explains about pharma management discusses uses and contradictions of Prostavital. PROSTAVITAL 30 Capsules Vitamin E-The compound has a dramatic effect on the androgen receptor, a protein in the body that is vital to the growth of prostate cells, including its cancer cells...
  12. P

    Data management tools in preclinical development

    Description The PPT explains about CHROMATOGRAPHIC DATA SYSTEMS (CDS) , LABORATORY INFORMATION MANAGEMENT SYSTEMS (LIMS), LIMS Hardware and Architectures and their evloution types and development. Computers as data analysis & data management tools in preclinical development INTRODUCTION •...
  13. P

    Genzyme GelTex Pharmaceuticals JV

    Description The doc explains on the joint venture of Genzyme GelTex Pharmaceuticals by studying NPV, value, investments Genzyme/GelTex Pharmaceuticals Joint venture Advanced Corporate Finance Case Background: Genzyme Corporation, a large biotech company based in United States is entering into...
  14. P

    Pharma industry regulation

    Description This ppt contains: HISTORY OF PHARMACEUTICAL INDUSTRY; THE FOOD AND DRUG ACT; THE FEDERAL FOOD, DRUG AND COSMETIC ACT; WAXMAN-HATCH ACT. NOTE ON PHARMACEUTICAL INDUSTRY REGULATION GROUP F1 HISTORY OF PHARMACEUTICAL INDUSTRY BEFORE WORLD WAR 1 Use of crude Botanical products and...
  15. P

    Lifecycle mgmt in the pharmaceutical industry

    Description This is a presentation explains about what is lifecycle management, why LCM has become so important these days, strategies that are currently being used by pharmaceutical companies and effective LCM strategies. Presentation on Lifecycle management in the pharmaceutical industry: The...
  16. P

    NPV and IRR Calculator

    Description The spreadsheet about model will help you to calculate NPV and IRR with ease. NPV AND IRR RULES 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 A B C NPV RULE FOR CAPITAL BUDGETING D E F G H Choose a project if it costs less than the PV of its cash flows. More...
  17. P

    Capital Budgeting Model

    Description The Spreadsheet model covers capital budgeting in detail. CAPITAL BUDGETING WORKSHEET 5 Equity Analysis of a Project INPUT SHEET: USER ENTERS ALL BOLD NUMBERS INITIAL INVESTMENT Initial Investment= Opportunity cost (if any)= Lifetime of the investment Salvage Value at end of...
  18. P

    WACC Calculator

    Description Weighted Average Cost of Capital Calculator in spreadsheet. ESTIMATING THE WEIGHTED AVERAGE COST OF CAPITAL WACC CALCULATOR Input cells are in yellow. Comparable Companies Firm 1 DATA Amount of equity Amount of debt Tax rate Equity beta 1+ (1-T)D/E Unlevered equity beta 200 100 40%...
  19. P

    Economic Quantity Order Model

    Description EOQ model in excel for Operations management. Inventory Management using EOQ Holding Cost Order Cost Unit Cost Demand Order Quantity Holding Cost Q hC(Q/2) 4.41 $40.33 8.82 $80.66 13.22 $121.00 17.63 $161.33 22.04 $201.66 26.45 $241.99 30.86 $282.32 35.26 $322.66 39.67 $362.99 44.08...
  20. P

    Capital Structure Model

    Description Excel Model to calculate structure based on debt percentages. A 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Tax rate Debt in the capital structure EBIT Interest Profit before taxes Taxes Profit after...
Back
Top